According to Accelerate Diagnostics's latest financial reports the company's total debt is $39.22 M. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2022-12-31 | $77.54 M | -30.22% |
2021-12-31 | $0.11 B | -25.92% |
2020-12-31 | $0.14 B | 11.87% |
2019-12-31 | $0.13 B | 11.66% |
2018-12-31 | $0.12 B | |
2016-12-31 | $N/A | -100% |
2015-12-31 | $0.01 M | -91.88% |
2014-12-31 | $0.16 M | |
2013-12-31 | $N/A |
Company | Total debt | differencediff. | Country |
---|---|---|---|
Thermo Fisher Scientific TMO | $34.91 B | 88,928.56% | ๐บ๐ธ USA |
Becton Dickinson BDX | $16.11 B | 40,975.98% | ๐บ๐ธ USA |
PerkinElmer
PKI | $4.50 B | 11,398.73% | ๐บ๐ธ USA |
Bruker BRKR | $1.37 B | 3,417.59% | ๐บ๐ธ USA |
NanoString Technologies NSTG | $0.24 B | 531.57% | ๐บ๐ธ USA |
Bio-Rad Laboratories BIO | $1.40 B | 3,483.48% | ๐บ๐ธ USA |